DPP9 and clear cell renal carcinoma: Unlike our findings, they found that DPP9 inhibited ferroptosis and induced sorafenib resistance in Clear Cell Renal Cell Carcinoma not by regulating the NRF2 downstream target gene NQO1, but by regulating SLC7A11.